For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Why and how transwomen are switching to funded oestrogen gel
Why and how transwomen are switching to funded oestrogen gel

With oestrogen gel now funded without restrictions, sexual health specialist Massimo Giola explains who would benefit from using it for feminisation and how switching from tablets or patches might occur
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Scheres LJJ, Selier NLD, Nota NM, et al. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen. J Thromb Haemost 2021;19(4):1029–37.
2. Coleman E, Radix AE, Bouman WP, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health 2022;23(Suppl 1):S1–259.
3. Veale JF. Transgender-related stigma and gender minority stress-related health disparities in Aotearoa New Zealand: hypercholesterolemia, hypertension, myocardial infarction, stroke, diabetes, and general health. Lancet Reg Health West Pac 2023;39:100816.
4. Australasian Menopause Society. AMS Guide to MHT/HRT Doses New Zealand only. 21 October 2024.